Yuelin Han, student at the Tongji Hospital, Wuhan, China presents a systematic review and network meta-analysis evaluating the the efficacy and safety of perioperative immunotherapy combinations for resectable NSCLC.

With the educational support of:

You may also be interested in:

The remaining challenges with neo-adjuvant immunotherapy in early-stage NSCLC

A propensity-based analysis of SBRT & VATS for early-stage lung cancer

Two good options for patients with stage III NSCLC

Tags:

poster